Your browser is not supported.

To view this content, please use one of the following browsers:

  • Microsoft Edge
  • Chrome
  • Safari
  • Home
  • Resources
  • Webinars & Videos
  • Introducing ▼ REZZAYO® (rezafungin) the first once weekly echinocandin indicated for the treatment of invasive candidiasis in adults.

Introducing ▼ REZZAYO® (rezafungin) the first once weekly echinocandin indicated for the treatment of invasive candidiasis in adults.

Introducing REZZAYO® (rezafungin) the first once weekly echinocandin indicated for the treatment of invasive candidiasis in adults.

Get access to exclusive content and news updates:

Subscribe Now
calendar
time 27:15
language English
Job Code: UK-FLU-2200010 | May 2024

Professor Tihana Bicanic

Professor Tihana Bicanic

Reader and Consultant in Infectious diseases at St George's University of London.

oliver

Professor Oliver Cornely

Director & Chair of Translational Research at the CECAD Institute of the University of Cologne, and Scientific Director of the Center for Clinical Trials. Clinically, he serves as Infectious Diseases Consultant at the University Hospital of Cologne, Germany.

Professor Matteo Bassetti

Professor Matteo Bassetti

Head of the Infectious Diseases Clinic of the Policlinico San Martino University Hospital in Genoa and Professor of Infectious Diseases of the University of Genoa, Italy.

Related Webinars